Characteristic | Apixaban (n = 314) |
Warfarin (n = 785) |
P value |
---|---|---|---|
Past medical history, n (%) | |||
History of VTE | 70 (22.3) | 305 (38.9) | <.01 |
History of bleeding | 7 (2.2) | 24 (3.1) | .55 |
History of trauma in the prior 6 months | 4 (1.3) | 18 (2.3) | .35 |
History of surgery in the prior 6 months | 21 (6.7) | 29 (3.7) | .04 |
Liver disease | 13 (4.1) | 35 (4.5) | .87 |
Index admission laboratory values, mean ± SD | |||
Lowest platelet count (K/cmm) | 198 ± 77 | 199 ± 77 | .91 |
Lowest hemoglobin count (mg/dL) | 10.9 ± 2.6 | 10.7 ± 2.3 | .03 |
Discharge serum creatinine (mg/dL) | 1.40 ± 1.55 | 1.27 ± 1.31 | .05 |
Length of initial hospital stay (days), mean ± SD | 6.5 ± 7.2 | 8.5 ± 8.8 | .09 |
Concomitant medications at discharge, n (%) | |||
NSAIDs | 21 (6.7) | 57 (7.3) | .80 |
Aspirin | 99 (31.5) | 251 (32.0) | .94 |
Clopidogrel | 25 (8.0) | 40 (5.1) | .09 |
Prasugrel | 0 | 0 | – |
Ticagrelor | 1 (0.3) | 1 (0.1) | .49 |
Estrogen therapy | 1 (0.3) | 6 (0.8) | .68 |
Cilostazol | 1 (0.3) | 5 (0.6) | .68 |
SSRI/SNRI | 48 (15.3) | 148 (18.9) | .19 |